Clinical Trial Update: Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update testing a regimen including bempedoic acid (an ACL inhibitor) in people with HIV to reduce dyslipidemia and cardiovascular risk. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cardiovascular Disease
• Dyslipidemia
• HIV Infection

Drugs mentioned

• Nexletol (bempedoic acid)

Snippet

Sponsor: Priscilla Hsue, MD | Conditions: Dyslipidemias, Cardiovascular Diseases | Phase 2 | Status: RECRUITING